IEQ Capital’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Buy
614,189
+178,922
+41% +$359K 0.01% 882
2025
Q4
$596K Buy
435,267
+59,209
+16% +$78.1K ﹤0.01% 1250
2025
Q3
$466K Buy
376,058
+189,880
+102% +$226K ﹤0.01% 1330
2025
Q2
$210K Buy
186,178
+120,000
+181% +$159K ﹤0.01% 1592
2025
Q1
$96.6K Hold
66,178
﹤0.01% 1484
2024
Q4
$141K Hold
66,178
﹤0.01% 1245
2024
Q3
$185K Hold
66,178
﹤0.01% 1069
2024
Q2
$154K Sell
66,178
-175
-0.3% -$516 ﹤0.01% 932
2024
Q1
$297K Hold
66,353
﹤0.01% 774
2023
Q4
$213K Buy
66,353
+175
+0.3% +$496 ﹤0.01% 825
2023
Q3
$210K Buy
66,178
+20,648
+45% +$90.5K ﹤0.01% 825
2023
Q2
$226K Buy
45,530
+2,530
+6% +$13.7K ﹤0.01% 774
2023
Q1
$212K Buy
43,000
+21,000
+95% +$135K ﹤0.01% 805
2022
Q4
$138K Sell
22,000
-21,000
-49% -$194K ﹤0.01% 755
2022
Q3
$464K Hold
43,000
0.01% 549
2022
Q2
$490K Hold
43,000
0.01% 478
2022
Q1
$392K Hold
43,000
0.01% 565
2021
Q4
$642K Sell
43,000
-47
-0.1% -$829 0.01% 400
2021
Q3
$1.11M Buy
43,047
+47
+0.1% +$1.12K 0.03% 279
2021
Q2
$1.12M Hold
43,000
0.03% 239
2021
Q1
$1.52M Hold
43,000
0.06% 165
2020
Q4
$1.08M Hold
43,000
0.05% 160
2020
Q3
$1.62M Hold
43,000
0.09% 125
2020
Q2
$1.84M Hold
43,000
0.12% 110
2020
Q1
$836K Hold
43,000
0.07% 161
2019
Q4
$1.12M Buy
+43,000
New +$1.18M 0.1% 140

Other funds holding ALLO